[ad_1] Novartis AG on Friday said it would spin off its Alcon eye-care unit, a business analysts said it could be valued at more than $ 20 billion, the latest move by …
Read More »Novartis hands over to investors Alcon spin-off and $ 5 billion stock repurchase
[ad_1] ZURICH (Reuters) – Novartis ( NOVN.S ) plans to sell its Alcon eye care business to shareholders and buy back up to $ 5 billion of stock, then that the general …
Read More »